Genotyping and serotyping profiles showed weak Jka presentation for previously typed as Jknull donors.

By combining the tube method and gel card method in serology, along with complementary genetic testing, the possibility of misinterpreting weak Jka expression was eliminated, and we were able to provide Jknull blood for safe clinical transfusion.